
    
      This study is a multi-center, single-arm, open labeling clinical trial, which the objective
      is to evaluate the safety and Efficacy of donepezil in Alzheimer's disease( AD) patients in
      China, and investigate the relationship between Apo-E gene type with adverse events of
      donepezil.
    
  